SANDOZ ESTRADIOL DERM 100 PATCH

Ülke: Kanada

Dil: İngilizce

Kaynak: Health Canada

Aktif bileşen:

ESTRADIOL (ESTRADIOL HEMIHYDRATE)

Mevcut itibaren:

SANDOZ CANADA INCORPORATED

ATC kodu:

G03CA03

INN (International Adı):

ESTRADIOL

Doz:

100MCG

Farmasötik formu:

PATCH

Kompozisyon:

ESTRADIOL (ESTRADIOL HEMIHYDRATE) 100MCG

Uygulama yolu:

TRANSDERMAL

Paketteki üniteler:

8

Reçete türü:

Prescription

Terapötik alanı:

ESTROGENS

Ürün özeti:

Active ingredient group (AIG) number: 0106457037; AHFS:

Yetkilendirme durumu:

APPROVED

Yetkilendirme tarihi:

2006-01-11

Ürün özellikleri

PRODUCT MONOGRAPH
SANDOZ ESTRADIOL DERM 50, 75 AND 100 ESTRADIOL HEMIHYDRATE (ESTRADIOL-17Β)
TRANSDERMAL THERAPEUTIC SYSTEM
4, 6 AND 8 MG ESTRADIOL PATCHES
CORRESPONDING TO
50 MCG/DAY, 75 MCG/DAY AND 100 MCG/DAY DELIVERY
ESTROGEN
Sandoz Canada Inc.
145 Jules-Léger
Date of Revision: March 19, 2009
Boucherville, QC, Canada
J4B 7K8
CONTROL NUMBER: 120474
_ _
_Sandoz Estradiol Derm _
_Page 2 of 34 _
_ _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL
INFORMATION.........................................................................................
3
SUMMARY
PRODUCT
INFORMATION...............................................................................................................
3
INDICATIONS
AND
CLINICAL
USE
....................................................................................................................
3
CONTRAINDICATIONS
.........................................................................................................................................
3
WARNINGS
AND
PRECAUTIONS
........................................................................................................................
4
ADVERSE
REACTIONS........................................................................................................................................
11
DRUG
INTERACTIONS
........................................................................................................................................
12
DOSAGE
AND
ADMINISTRATION
....................................................................................................................
14
OVERDOSAGE
......................................................................................................................................................
16
ACTIONS
AND
CLINICAL
PHARMACOLOGY.................................................................................................
16
STORAGE
AND
STABILITY
.....................................................................................................................